ClinCalc Pro
Menu
gi-hepatology oncology

GALAD Model for HCC Diagnosis

GALAD biomarker model for early detection of hepatocellular carcinoma (HCC) in patients with cirrhosis or chronic hepatitis. Combines sex, age, AFP-L3, AFP, and DCP (PIVKA-II).

References

Related

Curated clinical cross-links plus same-class fallbacks.

Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.